LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.98 | 27.76 | 618 | 941 | 0.6567 | 0.8412 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.98 | 27.76 | 820 | 941 | 0.8713 | 0.9465 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.98 | 27.76 | 42 | 941 | 0.0446 | 0.0849 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.98 | 27.76 | 1180 | 941 | 1.2538 | 1.0910 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.68 | 27.76 | 707 | 1119 | 0.6318 | 0.8350 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.68 | 27.76 | 805 | 1119 | 0.7194 | 0.8802 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.68 | 27.76 | 50 | 1119 | 0.0447 | 0.1167 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.68 | 27.76 | 1189 | 1119 | 1.0626 | 1.0229 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 22.39 | 27.76 | 752 | 1305 | 0.5759 | 0.8109 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 22.39 | 27.76 | 837 | 1305 | 0.6410 | 0.8462 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 22.39 | 27.76 | 65 | 1305 | 0.0498 | 0.1655 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 22.39 | 27.76 | 1202 | 1305 | 0.9206 | 0.9704 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 24.09 | 27.76 | 802 | 1461 | 0.5487 | 0.8007 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 24.09 | 27.76 | 867 | 1461 | 0.5932 | 0.8254 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 24.09 | 27.76 | 65 | 1461 | 0.0445 | 0.1604 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 24.09 | 27.76 | 1249 | 1461 | 0.8545 | 0.9458 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.79 | 27.76 | 775 | 1605 | 0.4828 | 0.7661 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.79 | 27.76 | 835 | 1605 | 0.5202 | 0.7887 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.79 | 27.76 | 73 | 1605 | 0.0455 | 0.1796 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.79 | 27.76 | 1213 | 1605 | 0.7557 | 0.9066 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.49 | 27.76 | 807 | 1723 | 0.4683 | 0.7608 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.49 | 27.76 | 865 | 1723 | 0.5020 | 0.7815 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.49 | 27.76 | 88 | 1723 | 0.0511 | 0.2138 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.49 | 27.76 | 1262 | 1723 | 0.7324 | 0.8981 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.19 | 27.76 | 791 | 1863 | 0.4246 | 0.7367 | MN20160318_Q01 | D07 |